Impact of RSV Preventive Strategies on Hospitalizations for Bronchiolitis in Infants
Pediatric Pulmonology · 2026-06 · 61 (6)
DOI: 10.1002/ppul.71689 ↗At a glance
Journal article in Pediatric Pulmonology, published online on 2026-06-10. Written by Marine Tarizzo and 7 co-authors. Institution: Inserm U938, Centre de Recherche Saint-Antoine (CRSA), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau, Service de Pneumologie Pédia…. Major MEDLINE topics: Respiratory Syncytial Virus Infections, Hospitalization, Respiratory Syncytial Virus Vaccines, Bronchiolitis. Cited 3 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Introduction
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and hospitalization in infants. Since 2023, France has implemented two preventive strategies aimed at reducing RSV burden: long‐acting monoclonal antibody nirsevimab and RSV vaccine for pregnant women, the latter becoming available from September 2024. This study aimed to assess the impact of RSV preventive strategies on the clinical severity and viral epidemiology of bronchiolitis in hospitalized infants. Material and Methods We conducted a retrospective study at Armand Trousseau University Hospital, including infants under 12 months hospitalized for a first episode of bronchiolitis between October and March during four winter seasons (2021–2025). Clinical and virological data were compared between the pre‐intervention (2021–2023) and post‐intervention (2023–2025) periods. Subgroup analyses were performed based on RSV infection and prophylaxis status.
Results
A total of 509 infants were included (292 pre‐intervention, 217 post‐intervention). Post‐intervention infants were older (median, 3.2 vs. 1.9 months, p = 0.001), required less oxygen therapy (58.5% vs. 70.9%, p < 0.001), and had shorter hospital stays (median, 3.0 vs. 5.0 days, p < 0.001). Compared with untreated infants ( n = 140), those who received nirsevimab ( n = 67) had significantly lower rates of RSV infection and viral co‐infections (OR: 0.15 (95%CI: 0.08–0.29), p < 0.001; and 40.4% vs. 25.0%, p = 0.035), while human metapneumovirus was detected more frequently (OR: 11.00 (95%CI: 3.50–34.55), p < 0.001). Discussion and Conclusion During the period following the introduction of RSV preventive strategies, a reduced hospital burden, milder clinical courses, and shifts in viral epidemiology were observed. These findings support the continued implementation of RSV immunoprophylaxis and underscore the importance of ongoing surveillance to monitor its long‐term impact.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Inserm U938, Centre de Recherche Saint-Antoine (CRSA), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Sorbonne Université, Paris, France.
- Laboratory of Childhood Genetic Diseases, Inserm UMR_S933, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Sorbonne Université, Paris, France.
ORCID profiles: Blandine Prevost, Elora Peulier-Maitre, Loïc Guillot, Nadia Nathan, Harriet Corvol
Cite
APA
Tarizzo, M., Mesinèle, J., Prevost, B., Denamur, S., Peulier-Maitre, E., Guillot, L., Nathan, N., & Corvol, H. (2026). Impact of RSV Preventive Strategies on Hospitalizations for Bronchiolitis in Infants. Pediatric Pulmonology, 61(6). https://doi.org/10.1002/ppul.71689
Vancouver
Tarizzo M, Mesinèle J, Prevost B, Denamur S, Peulier-Maitre E, Guillot L, et al. Impact of RSV Preventive Strategies on Hospitalizations for Bronchiolitis in Infants. Pediatric Pulmonology. 2026;61(6). doi:10.1002/ppul.71689
BibTeX
@article{Tarizzo2026,
author = {Tarizzo, Marine and Mesinèle, Julie and Prevost, Blandine and Denamur, Sophie and Peulier-Maitre, Elora and Guillot, Loïc and Nathan, Nadia and Corvol, Harriet},
title = {Impact of RSV Preventive Strategies on Hospitalizations for Bronchiolitis in Infants},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {6},
doi = {10.1002/ppul.71689}
}
EUVIMED